INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income Statement [Abstract]
PATIENT REVENUES, NET	$ 117,965	$ 118,630	$ 356,195	$ 354,145
OTHER OPERATING INCOME	9,563	0	14,711	0
EXPENSES:
Operating	98,706	95,591	289,340	284,643
Lease and rent expense	13,524	13,251	40,560	39,480
Professional liability	2,249	1,737	6,202	5,182
Government settlement expense			0	3,100
General and administrative	6,487	6,902	20,125	21,267
Depreciation and amortization	2,098	2,279	6,663	6,812
Total expenses	123,064	119,760	362,890	360,484
OPERATING INCOME (LOSS)	4,464	(1,130)	8,016	(6,339)
OTHER INCOME (EXPENSE):
Other income	90	25	614	207
Interest expense, net	(1,172)	(1,554)	(3,841)	(4,424)
Total other expense	(1,082)	(1,529)	(3,227)	(4,217)
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	3,382	(2,659)	4,789	(10,556)
BENEFIT (PROVISION) FOR INCOME TAXES	(209)	741	(287)	(15,544)
INCOME (LOSS) FROM CONTINUING OPERATIONS	3,173	(1,918)	4,502	(26,100)
LOSS FROM DISCONTINUED OPERATIONS:
Operating loss, net of tax benefit	(374)	(3,689)	(1,004)	(7,449)
Gain on lease modification, net of tax	0	733	0	733
Loss from discontinued operations	(374)	(2,956)	(1,004)	(6,716)
NET INCOME (LOSS)	$ 2,799	$ (4,874)	$ 3,498	$ (32,816)
Per common share – basic
Continuing operations (in dollars per share)	$ 0.48	$ (0.30)	$ 0.68	$ (4.04)
Discontinued operations (in dollars per share)	(0.06)	(0.45)	(0.15)	(1.04)
Net income (loss) per common share – basic (in dollars per share)	0.42	(0.75)	0.53	(5.08)
Per common share – diluted
Continuing operations (in dollars per share)	0.48	(0.30)	0.67	(4.04)
Discontinued operations (in dollars per share)	(0.06)	(0.45)	(0.15)	(1.04)
Net income (loss) per common share – diluted (in dollars per share)	$ 0.42	$ (0.75)	$ 0.52	$ (5.08)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic (in shares)	6,577	6,470	6,606	6,455
Diluted (in shares)	6,626	6,470	6,676	6,455